Mexico Takes Action Against Alleged Monopolistic Practices in Medicinal Oxygen Market
In a recent announcement, Mexican antitrust watchdog Cofece notified various economic agents of a statement of probable responsibility, alleging that they have abused their dominant positions to engage in anticompetitive practices in the market for the production, distribution, and sale of medicinal oxygen and related services across the country.
These alleged anticompetitive behaviors, collectively referred to as “relative monopolistic practices,” have been detailed in the statement of probable responsibility issued by Cofece’s investigative arm.
This development marks the launch of a trial-like procedure, where the accused parties will have the chance to assert their rights, present evidence, and make arguments in their defense.
Following this procedure, the Board of Commissioners of Cofece will make a determination in accordance with the law.
If the existence of relative monopolistic practices is proven, the Commission has the authority to order remedies and other steps to eliminate these behaviors, with penalties including fines of up to 8% of the offending company’s annual income
Featured News
European Music Streaming Firms Rally Against Apple’s Proposed Remedies
May 9, 2024 by
CPI
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI